The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Groninger James G since 2005.
The trader's CIK number is 1013420.
At the time of the last reporting, Groninger James G was the Director of Nps Pharmaceuticals Inc. (stock ticker symbol NPSP).
Also see all insider trading activities at Nps Pharmaceuticals Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2014 | NPSP | 0 | $0 | 6,000 | $226,200 | 15,188 | $0 |
2013 | NPSP | 0 | $0 | 25,225 | $527,255 | 13,000 | $107,590 |
2005 | NPSP | 0 | $0 | 3,350 | $40,809 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2007 | CYDS | 0 | $0 | 0 | $0 | 500 | $65 |
2006 | CYDS | 0 | $0 | 7,850 | $38,977 | 15,500 | $6,559 |
1. Nps Pharmaceuticals Inc (NPSP)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2014-02-13 | NPSP | Sale | 6,000 | 37.70 | 226,200 |
2014-02-13 | NPSP | Option Ex | 15,188 | .00 | 0 |
2013-12-23 | NPSP | Option Ex | 3,000 | 21.73 | 65,190 |
2013-12-23 | NPSP | Sale | 3,000 | 29.50 | 88,500 |
2013-08-20 | NPSP | Option Ex | 10,000 | 4.24 | 42,400 |
2013-08-20 | NPSP | Sale | 16,900 | 23.21 | 392,215 |
2013-02-07 | NPSP | Sale | 5,325 | 8.74 | 46,540 |
2005-07-28 | NPSP | Sale | 1,000 | 10.87 | 10,870 |
2005-05-23 | NPSP | Sale | 2,350 | 12.74 | 29,939 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2007-06-18 | CYDS | Option Ex | 500 | .13 | 65 |
2006-04-17 | CYDS | Option Ex | 7,650 | .15 | 1,132 |
2006-01-10 | CYDS | Sale | 5,500 | 4.96 | 27,280 |
2006-01-11 | CYDS | Sale | 1,050 | 4.95 | 5,197 |
2006-01-17 | CYDS | Option Ex | 1,300 | .16 | 208 |
2006-01-17 | CYDS | Sale | 1,300 | 5.00 | 6,500 |
2006-01-10 | CYDS | Option Ex | 5,500 | .91 | 4,988 |
2006-01-11 | CYDS | Option Ex | 1,050 | .22 | 231 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Groninger James G (Director of Nps Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.